Skip to main content

AstraZeneca ChAdOx1-S COVID-19 vaccine

Update - Expert review finds no evidence of increased risk of anaphylaxis
Update - Expert review finds no evidence of increased risk of anaphylaxis
Published

Help us improve the Therapeutic Goods Administration site